TY - JOUR
T1 - Acute stroke imaging research roadmap
AU - Wintermark, Max
AU - Albers, Gregory W.
AU - Alexandrov, Andrei V.
AU - Alger, Jeffry R.
AU - Bammer, Roland
AU - Baron, Jean Claude
AU - Davis, Stephen
AU - Demaerschalk, Bart M.
AU - Derdeyn, Colin P.
AU - Donnan, Geoffrey A.
AU - Eastwood, James D.
AU - Fiebach, Jochen B.
AU - Fisher, Marc
AU - Furie, Karen L.
AU - Goldmakher, Gregory V.
AU - Hacke, Werner
AU - Kidwell, Chelsea S.
AU - Kloska, Stephan P.
AU - Köhrmann, Martin
AU - Koroshetz, Walter
AU - Lee, Ting Yim
AU - Lees, Kennedy R.
AU - Lev, Michael H.
AU - Liebeskind, David S.
AU - Ostergaard, Leif
AU - Powers, William J.
AU - Provenzale, James
AU - Schellinger, Peter
AU - Silbergleit, Robert
AU - Sorensen, Alma Gregory
AU - Wardlaw, Joanna
AU - Wu, Ona
AU - Warach, Steven
PY - 2008/5
Y1 - 2008/5
N2 - The recent "Advanced Neuroimaging for Acute Stroke Treatment" meeting on September 7 and 8, 2007 in Washington DC, brought together stroke neurologists, neuroradiologists, emergency physicians, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), industry representatives, and members of the US Food and Drug Administration (FDA) to discuss the role of advanced neuroimaging in acute stroke treatment. The goals of the meeting were to assess state-of-the-art practice in terms of acute stroke imaging research and to propose specific recommendations regarding: (1) the standardization of perfusion and penumbral imaging techniques, (2) the validation of the accuracy and clinical utility of imaging markers of the ischemic penumbra, (3) the validation of imaging biomarkers relevant to clinical outcomes, and (4) the creation of a central repository to achieve these goals. The present article summarizes these recommendations and examines practical steps to achieve them.
AB - The recent "Advanced Neuroimaging for Acute Stroke Treatment" meeting on September 7 and 8, 2007 in Washington DC, brought together stroke neurologists, neuroradiologists, emergency physicians, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), industry representatives, and members of the US Food and Drug Administration (FDA) to discuss the role of advanced neuroimaging in acute stroke treatment. The goals of the meeting were to assess state-of-the-art practice in terms of acute stroke imaging research and to propose specific recommendations regarding: (1) the standardization of perfusion and penumbral imaging techniques, (2) the validation of the accuracy and clinical utility of imaging markers of the ischemic penumbra, (3) the validation of imaging biomarkers relevant to clinical outcomes, and (4) the creation of a central repository to achieve these goals. The present article summarizes these recommendations and examines practical steps to achieve them.
UR - http://www.scopus.com/inward/record.url?scp=44449089055&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44449089055&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.107.512319
DO - 10.1161/STROKEAHA.107.512319
M3 - Article
C2 - 18403743
AN - SCOPUS:44449089055
SN - 0195-6108
VL - 29
SP - E23-E30
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 5
ER -